Unknown
NA
INTERVENTIONAL
NCT01296269
Effects of Intranasal Oxytocin and Vasopressin on Social Behavior
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The purpose of this study is to investigate the role of a one-time intranasal administration of the oxytocin, vasopressin, or placebo on prosocial decision making such as cooperation and altruism in a healthy population of student controls.
Interventions
Name:
Oxytocin
Type:
DRUG
Description:
one-time intranasal administration, 24 International Units, 5 puffs for each nostril
Name:
Arginine Vasopressin
Type:
DRUG
Description:
one-time intranasal administration, 20 International Units, 5 puffs in each nostril
Name:
placebo
Type:
DRUG
Description:
contains all the ingredients as in the oxytocin and vasopressin conditions, save for the active ingredient, one time intranasal administration, 5 puffs in each nostril
Primary Outcomes
Measure:
allocations of monetary units
TimeFrame:
approximately 45 minutes after intranasal administration of vasopressin, oxytocin, or placebo
Description:
Participants will make decisions regarding the allocation of monetary units between themselves and other participants. We will measure the quantity of monetary units kept for themselves vs. given to other participants
Trial Information
NCT ID
NCT01296269
Status
Unknown
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Hadassah Medical Organization
Last Updated
December 15, 2025